Overview
Injury to the hepatic veins (HV) can significantly impact liver function and graft survival, particularly in the context of liver transplantation and certain surgical interventions like portal vein embolization (PVE). This condition often arises post-transplantation or following surgical procedures aimed at altering liver blood flow distribution. Understanding the pathophysiology, diagnostic approaches, management strategies, and long-term prognosis is crucial for optimizing patient outcomes. This guideline synthesizes evidence from key studies to provide clinicians with a comprehensive framework for addressing hepatic vein injuries.
Pathophysiology
Hepatic vein injury can lead to substantial alterations in hepatic hemodynamics, affecting both the affected and contralateral lobes of the liver. A prospective study by [PMID:12470105] elucidated the impact of PVE on liver lobe volumes and function. Following PVE, the non-PVE-treated lobe exhibited a significant increase in size, growing by 137% ± 30%, while the PVE-treated lobe decreased to 87% ± 15% of its original size. Despite these dramatic changes in lobar blood flow distribution, the study highlighted that overall hepatic function remained stable, as evidenced by maintained plasma clearance of sorbitol and antipyrine. This suggests that while there are pronounced anatomical changes, the functional capacity of the liver as a whole can be preserved, which is critical for surgical planning and patient management. The preservation of total liver volume and plasma flow underscores the liver's compensatory mechanisms and resilience in the face of such interventions.
Diagnosis
Accurate diagnosis of hepatic vein injury is essential for timely intervention and management. Computed tomography angiography (CTA) has emerged as a reliable imaging modality for evaluating the patency of the middle hepatic vein (MHV) and other hepatic veins post-transplantation. A study by [PMID:31563244] utilized CTA to monitor graft patency at multiple time points—7 days, 20 days, 90 days, and 1 year post-transplantation. This approach provided consistent and detailed assessments, facilitating early detection of complications such as thrombosis or stenosis. Clinically, CTA not only aids in diagnosing immediate post-operative issues but also in long-term surveillance, allowing for proactive management strategies to mitigate potential graft failure. Regular imaging follow-up is therefore recommended to ensure sustained patency and graft integrity.
Management
The management of hepatic vein injuries involves careful consideration of graft materials and surgical techniques to optimize patency and long-term outcomes. A retrospective analysis of 521 patients undergoing living donor liver transplantation (LDLT) with right liver grafts, as reported by [PMID:31563244], highlighted significant differences in patency rates between synthetic and biologic grafts. Synthetic grafts, particularly those made of polytetrafluoroethylene (PTFE) and expanded polytetrafluoroethylene (PETE), demonstrated significantly higher patency rates compared to biologic grafts at both short-term (7 days, 1 year) and long-term follow-up (P < 0.05). Specifically, PTFE and PETE grafts showed patency rates of 27% and 26.4%, respectively, at 1 year, which were notably higher than other materials such as great saphenous vein (GSV), portal vein (PV), cadaveric iliac artery (CIA), and cadaveric inferior vena cava (CIV). These findings underscore the clinical preference for synthetic grafts due to their superior durability and lower risk of complications like infection and rejection.
In surgical practice, the choice of graft material should be guided by these outcomes, prioritizing synthetic options like PTFE and PETE to enhance long-term patency and graft survival. Additionally, meticulous surgical technique and adherence to best practices in hemostasis and graft handling are crucial to minimize the risk of immediate post-operative complications that could compromise vein patency. Postoperative monitoring and early intervention for signs of thrombosis or stenosis are also vital components of effective management.
Prognosis & Follow-up
The prognosis following hepatic vein injury is closely tied to the patency of the reconstructed veins, with long-term outcomes significantly influenced by early graft patency rates. According to [PMID:31563244], patency rates of reconstructed MHVs tend to decline over time, with notably lower rates observed at 1 year (ranging from 26.4% to 55.6% depending on the material used). This underscores the critical importance of achieving and maintaining early patency to ensure sustained graft function and patient survival. Despite the significant changes in lobar volumes observed post-PVE, as noted by [PMID:12470105], the total liver volume remains relatively stable, indicating preserved overall liver function. This stability suggests a positive prognostic implication, as it implies that compensatory mechanisms within the liver can mitigate the impact of localized injuries.
Regular follow-up is essential to monitor graft patency and liver function. Imaging studies, particularly CTA, should be conducted at predefined intervals (e.g., 7 days, 30 days, 90 days, and annually) to detect any signs of graft failure early. Clinicians should also be vigilant for clinical symptoms indicative of graft dysfunction, such as jaundice, ascites, or signs of portal hypertension, which may necessitate prompt reevaluation and intervention.
Key Recommendations
These recommendations aim to guide clinicians in making evidence-based decisions to manage hepatic vein injuries effectively, ensuring optimal patient outcomes through meticulous surgical techniques, material selection, and rigorous follow-up protocols.
References
1 Lee SH, Na GH, Choi HJ, Kim DG, You YK. Impact of the Reconstruction Material on the Patency of Middle Hepatic Vein in Living Donor Liver Transplantation Using the Right Liver. Transplantation proceedings 2019. link 2 Shimada R, Imamura H, Nakayama A, Miyagawa S, Kawasaki S. Changes in blood flow and function of the liver after right portal vein embolization. Archives of surgery (Chicago, Ill. : 1960) 2002. link
2 papers cited of 3 indexed.